SynAct Pharma AB (SYNACT) NPV
Sell:18.02 SEKBuy:18.21 SEK
0.64 SEK
(3.46%)
Prices delayed by at least 15 minutes
- This stock can be held in a
Stocks and Shares ISASell:18.02 SEK
Buy:18.21 SEK
Change:0.64 SEK
(3.46%)
0.64 SEK
(3.46%)Prices delayed by at least 15 minutes
Sell:18.02 SEK
Buy:18.21 SEK
Change:0.64 SEK
(3.46%)
0.64 SEK
(3.46%)Prices delayed by at least 15 minutes
Company Information
About this company
SynAct Pharma AB is a manufacturer of biological products. The Company is located in Lund, Sweden. It develops medicines for acute impairment in inflammatory diseases. The company's drug candidate AP1189 is intended for the treatment of arthritis including psoriasis arthritis.
Key people
Anders Kronborg
Chairman of the Board
Jeppe Oevlesen
Chief Executive Officer, Director
Bjoern Westberg
Chief Financial Officer
Thomas Boesen
Chief Operating Officer
Thomas Jonassen
Chief Scientific Officer
James Knight
Chief Business Officer
Sten Scheibye
Director
Sten Sorensen
Director
Click to see more
Key facts
- EPIC-
- LocationSweden
- SectorHealthcare
- IndustryBiotechnology & Drugs
- ISINSE0008241491
- Market capSEK 906.17m
- Employees6
- Shares in issue43.59m
- ExchangeStockholm Stock Exchange
- IndexSX All Share PI Market Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.